Second and Third Generational Advances in Therapies of the Immune-Mediated Kidney Diseases in Children and Adolescents
Therapy of immune-mediated kidney diseases has evolved during recent decades from the non-specific use of corticosteroids and antiproliferative agents (like cyclophosphamide or azathioprine), towards the use of more specific drugs with measurable pharmacokinetics, like calcineurin inhibitors (cyclos...
Main Authors: | Ryszard Grenda, Łukasz Obrycki |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Children |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9067/9/4/536 |
Similar Items
-
Immunosuppressive Therapy Protocols in Kidney Transplantation in Adults
by: Jasenko Karamehić, et al.
Published: (2006-08-01) -
Immunosuppressant Adherence Factors Differentiating Compliant and Non-Compliant Kidney Transplant Recipients
by: Piotr Ostrowski, et al.
Published: (2023-06-01) -
Immunosuppressive regimens following kidney transplantation in five European countries: The observational RECORD study
by: Miha Arnol, et al.
Published: (2020-09-01) -
Evaluation of the Pharmacotherapy Complexity Index in Patients of a Renal Transplant Clini
by: Dayani Galato, et al.
Published: (2022-06-01) -
Safety of Immunosuppressive Drugs Used as Maintenance Therapy in Kidney Transplantation: A Systematic Review and Meta-Analysis
by: Celline Cardoso Almeida, et al.
Published: (2013-09-01)